|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 601 13th Street NW |
Address2 | Suite 290 North |
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400693064-241
|
||||||||
|
6. House ID# 415240023
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Melanie Nathanson |
Date | 1/12/2021 11:00:03 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
P.L. 116-260/H.R. 133 - Consolidated Appropriations Act of 2021 - Issues related to the fight against COVID-19 including issues of vaccine distribution, testing policies and procedures and support of the nation's health care system, patients, families and their care providers.
H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed.
H.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.
Senate HEALS Act - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.
Issues related to Administration policies on testing for COVID-19 as well as back to work protocols that include testing.
H.R. 6074 - Implementation - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.
H.R. 6201 - Implementation- Families First Coronavirus Response Act - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe.
H.R. 748 - The CARES Act - Implementation- Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Melanie |
Nathanson |
Ms. |
|
|
Megan |
Hauck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
P.L. 116-260/H.R. 133 - Consolidated Appropriations Act of 2021 - Issues related to the fight against COVID-19 including issues of vaccine distribution, testing policies and procedures and support of the nation's health care system, patients, families and their care providers.
H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed.
H.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.
Senate HEALS Act - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Implementation - Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.
H.R. 6201 - Families First Coronavirus Response Act - Implementation - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe.
H.R. 748 - The CARES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Melanie |
Nathanson |
Ms. |
|
|
megan |
Hauck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |